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Abstract 
Consideration of the likely biosynthetic origins of incargranine B, which was originally assigned an 
unprecedented indolo[1.7]napthyridine structure, led us to hypothesize that a dipyrrolo-quinoline framework 
was a more biosynthetically feasible structure. We herein demonstrate that our biosynthetically inspired 
structural revision is correct through a short biomimetic synthesis of incargranine B. 
 
Main text 
Incargranine B (1) was isolated from Incarvillea mairei var. grandiflora in 2010 by Zhang and coworkers.
[1]
 
Analysis of the obtained spectroscopic data, particularly 1D and 2D NMR data, led Zhang and co-workers to 
propose an unprecedented indolo[1.7]napthyridine structure for incargranine B (1), as shown in Scheme 1. 





Scheme 1. Our proposed biogenesis and structural revision for incargranine B (1).
[3]
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Consideration of the biosynthetic origins of incargranine B (1) led us to hypothesize that the proposed 
structure was incorrect. Incargranine B (1) formulates as a dimer that contains two glucose molecules, two 
phenylethanoid structures (C6C2) and two ornithine-derived units (C4N). Our efforts to discern a likely 
biosynthetic mechanism for a dimerization process were met with great difficulty.
[2]
 The proposed 
indolo[1.7]napthyridine core would necessitate the cleavage and formation of an unusually high number of 
bonds within any conventional biosynthesis. Although this insight does not constitute evidence against the 
proposed structure for incargranine B (1), it did lead to the development of the biosynthetic speculation 
outlined in Scheme 1. 
We considered that a phenylethanoid diamine 2 could be a biosynthetic precursor towards incargranine B (1) 
(Scheme 1).
[3]
 Thus, oxidative deamination of compound 2 and subsequent intramolecular condensation would 
result in iminium ion 3, which upon deprotonation would afford enamine 4. Iminium ion 3 and enamine 4 
could then combine through a domino Mannich/electrophilic aromatic substitution sequence, to afford a 
dipyrrolo-quinoline structure. This structure appeared to fit very well with all the spectroscopic data reported 
by Zhang for incargranine B (1).
[1]
 Therefore, we decided to embark upon a biomimetic synthesis of 
incargranine B (1) to investigate the feasibility of our biosynthetic proposal and structural revision. 
The synthesis began with DIBAL-H reduction of commercially available ethyl 4-bromobutanoate (Scheme 2). 
The resulting aldehyde was then protected as a cyclic acetal to afford alkyl bromide 5, isolated in 71% yield 
over the two steps.
[4]
 Alkyl bromide 5 was then used in a substitution reaction with commercially available 4-
aminophenethyl alcohol, using Hünig’s base and NaI. It was found that simply using an excess of 4-
aminophenethyl alcohol was sufficient to avoid di-alkylation, with mono-alkylated aniline 6 isolated in 83% 
yield. Aniline 6 was then treated with aqueous hydrochloric acid to deprotect the aldehyde and trigger the 
proposed biomimetic domino Mannich/electrophilic aromatic substitution sequence. This dimerization 
process, which forms two new C–C bonds, two new C–N bonds and three new rings in a single operation,[5] 
afforded two diastereomers 7 and 8 in a combined 50% yield.
[6]
 The relative stereochemistry of each 
diastereomer was established through single crystal X-ray analyses (Scheme 2).
[7] 
It should be noted that dimeric structures 7 and 8 were found to be unstable, particularly in solution when 
exposed to air. This instability was ascribed to autoxidation at the benzylic methine sites. Therefore, handling 
of these compounds, and derivatives thereof, in air was minimized and BHT (2,6-di-tert-butyl-4-
methylphenol) was added to stored samples. 
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H NMR spectrum of diastereomer 8 was strikingly similar to that reported for incargranine B (1), thus 
indicating that dimer 8 was indeed the agylcone of incargranine B (1). To definitively prove this, we needed to 
synthesize an analytical sample of the diglucoside of dimer 8. A screen of glucosyl donors and activators was 
undertaken to identify glucosidation conditions with high -selectivity, in order to avoid the production of 
unwated diastereomers. It was found that pivaloyl-protected trichloroacetimidate 9 was an effective and 
highly -selective glucosyl donor.[8] Dimer 8 was, therefore, treated with glucosyl donor 9, using TMSOTf as 
the activator to afford the two expected protected diglucoside diastereomers in 28% yield (Scheme 3).
[9]
 The 
pivaloyl groups were then removed in excellent yield using LiOH in MeOH/THF. 
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Scheme 3. Double glucosidation of aglycone 8. 
 
Professor Zhang very kindly provided pdf files of the processed 1D and 2D NMR spectra for natural 
incargranine B (1). Unfortunately, Professor Zhang was unable to provide us with either the original fid files 
or an authentic sample of the natural product. Nevertheless, spectroscopic data obtained on our synthetic 1:1 
diastereomeric mixture are a close match with the available data from the natural product.
[10]
 Furthermore, the 
optical rotation for our synthetic diastereomeric mixture, []D
20
 −16.7 (c 0.275, MeOH), is in good agreement 
with that reported for natural incargranine B (1), []D
20
 −12 (c 0.275, MeOH).[1] We therefore tentatively 
conclude that the natural product also exists as a diastereomeric mixture, although conclusive proof will 
require closer scrutiny of a sample isolated from the natural source.
[11]
 It is interesting to note that a 
biosynthetically related diglucosidic alkaloid, millingtonine,
[3b] 
 also exists as a mixture of diastereomers. The 
production of these pseudo-enantiomeric diastereomers in nature is presumably due to either a late-stage 
biosynthetic glucosidation of racemic (or scalemic) aglycones,
 
or a lack of stereochemical influence exerted 
by the sugars in non-enzyme mediated biosynthetic reactions. 
In summary, consideration of the biosynthetic origins of incargranine B (1) led us to suspect that the originally 
assigned indolo[1.7]napthyridine structure was incorrect. We proposed that a dipyrrolo-quinoline framework 
was a more biosynthetically feasible structure and have now demonstrated, through total synthesis, that this 
proposed structural revision was correct.
[12]
 We submit that our rapid synthesis of incargranine B (1), which 
requires a longest linear sequence of just six steps, provides very strong evidence that a similar dimerization 
process may be occurring in nature. This work not only demonstrates the great utility of biosynthetic 
considerations in devising synthetic strategies but also in aiding the determination/reassignment of natural 
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